PLGA nanoparticles augmented the anticancer potential of pentacyclic triterpenediol in vivo in mice-Reference-Cited by-同舟云学术

PLGA nanoparticles augmented the anticancer potential of pentacyclic triterpenediol in vivo in mice

Published:2016 Issue:78 Volume:6 Page:74586-74597
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Dubey Ravindra Dhar¹²³⁴,Saneja Ankit¹²³⁴,Qayum Arem⁵²³⁴,Singh Amarinder⁶²⁷⁴,Mahajan Girish⁵²³⁴,Chashoo Gousia⁵²³⁴,Kumar Amit⁸²⁷⁴,Andotra Samar S.⁸²⁷⁴,Singh Shashank K.⁵²³⁴,Singh Gurdarshan¹²³⁴⁶,Koul Surinder⁸²⁷⁴,Mondhe Dilip M.⁵²³⁴,Gupta Prem N.¹²³⁴⁶

Affiliation:

1. Formulation & Drug Delivery Division

2. CSIR-Indian Institute of Integrative Medicine

3. Jammu-Tawi-180001

4. India

5. Cancer Pharmacology Division

6. PK-PD-Toxicology Division

7. Jammu 180001

8. Natural Product Chemistry Division

Abstract

A novel pentacyclic triterpenediol (TPD), an anticancer lead fromBoswellia serrata, was encapsulated into PLGA nanoparticles, leading to enhancement in anticancer potential in EAT bearing mice model.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA14929D

Reference47 articles.

1. Natural products in anticancer therapy

2. The re-emergence of natural products for drug discovery in the genomics era

3. Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

4. Natural products and Pharma 2011: Strategic changes spur new opportunities

5. Natural products: A continuing source of novel drug leads

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cd44 Targeted Plga Nano-Medicine For Cancer Chemotherapy- A Comprehensive Review;Journal of Immunology and Clinical Microbiology;2023-11-16

2. Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity;European Journal of Medicinal Chemistry;2023-11

3. Antifibrotic Agent Mediated Tumor Microenvironment Modulation and Improved Nanomedicine Delivery in Solid Tumor;Molecular Pharmaceutics;2023-05-17

4. Biomimetic camouflaged nanoparticle-based folfirinox platform for optimizing clinical pancreatic cancer treatment;Nano Today;2023-02

5. Nanoparticles for Targeted Drug Delivery Systems with Cancer Therapy in Perspective;Drugs and a Methodological Compendium;2023